Reuters logo
2 months ago
BRIEF-Zealand Pharma: positive Phase 2a results with microdoses of dasiglucagon
May 23, 2017 / 6:56 AM / 2 months ago

BRIEF-Zealand Pharma: positive Phase 2a results with microdoses of dasiglucagon

1 Min Read

May 23 (Reuters) - ZEALAND PHARMA A/S

* POSITIVE PHASE 2A RESULTS WITH MICRODOSES OF DASIGLUCAGON SUPPORT USE IN A DUAL-HORMONE ARTIFICIAL PANCREAS SYSTEM

* DATA FROM THIS FIRST PHASE 2A TRIALS INDICATE THAT DASIGLUCAGON INCREASES BLOOD SUGAR LEVELS ACROSS ALL TESTED DOSE LEVELS

* RESULTS FROM SECOND PHASE 2A TRIAL ON USE OF DASIGLUCAGON IN DUAL-HORMONE ARTIFICIAL PANCREAS SYSTEM, ILET(TM), ARE EXPECTED AT END OF JUNE 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below